Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2020-12-10 Capital/Financing Update
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
ECS Successfully Completes $4.0 million Capital Raising 2 pages 156.7KB
Capital/Financing Update Classification · 100% confidence The document is an announcement dated 11 December 2020 from ECS Botanics Holdings Ltd regarding the successful completion of a $4.0 million capital raising through the placement of shares. It details the terms of the placement, use of proceeds, and strategic intentions following the capital raise. There is no indication of financial statements, quarterly or annual results, or detailed financial analysis. The content focuses on fundraising activities and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 4767 characters, which is consistent with an announcement rather than a full report.
2020-12-10 English
Proposed issue of Securities - ECS 5 pages 28.1KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a proposed issue of securities by ECS Botanics Holdings Ltd. It details the number of securities to be issued, the issue price, the proposed issue date, approvals required, and fees related to the placement. There is no financial performance data, management discussion, or detailed financial statements. The content focuses on capital raising activities and changes in the company's capital structure. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is over 6000 characters and contains substantive details about the placement, not just a brief notice or a report publication announcement.
2020-12-10 English
Trading Halt 2 pages 565.2KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from ECS Botanics Holdings Ltd regarding a trading halt requested pending the release of an announcement about a capital raising. It is dated 9 December 2020 and explicitly states that the trading halt is requested until the release of the capital raising announcement. The document does not contain any financial statements, detailed financial data, or the actual capital raising announcement itself. It is a short notice about the trading halt and the pending announcement. According to the rules, such a document is an announcement related to capital/financing activities but is not the actual capital raising update or report. Therefore, it should be classified as a Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content and context.
2020-12-08 English
UN approves WHO recommendation to reschedule cannabis 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 3 December 2020 from ECS Botanics Holdings Ltd. It reports on the United Nations approving the World Health Organization's recommendation to reschedule cannabis, which is a significant regulatory and business development update. The content is a news announcement about a regulatory change impacting the company's industry and business outlook. The document is relatively short (3212 characters) and does not contain financial statements, detailed financial data, or management discussion of financial results. It is not a report, transcript, or detailed presentation but rather a regulatory/business update announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance-related news that do not fit other specific categories.
2020-12-02 English
Response to ASX Price Query 5 pages 744.7KB
Regulatory Filings Classification · 100% confidence The document is a formal response from ECS Botanics Holdings Ltd to a price query issued by the ASX (Australian Securities Exchange) regarding unusual trading activity in the company's shares. The content includes the company's answers to specific questions about undisclosed information, compliance with listing rules, and market disclosures. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory compliance communication responding to a market query, typical of a regulatory filing. It does not constitute an annual report, earnings release, or any other financial report type. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-11-30 English
ECS Medicinal Cannabis Project and Regulatory Update 3 pages 784.4KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 23 November 2020 providing an update on the progress of ECS Botanics Holdings Ltd's medicinal cannabis project and recent regulatory changes affecting the industry. It discusses operational developments, regulatory environment improvements, strategic positioning, and future plans. There are no financial statements, detailed financial performance data, or comprehensive management analysis typical of annual or interim reports. The document is a corporate update aimed at shareholders and the market, focusing on project progress and regulatory context rather than financial results or governance changes. It is not a call transcript, audit report, or legal proceeding update. The content fits best as a Capital/Financing Update (CAP) since it relates to project development and strategic positioning influenced by regulatory changes, which can impact capital structure and financing outlook. The document length (7031 characters) and content confirm it is a substantive announcement rather than a brief notice or report publication announcement.
2020-11-22 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.